Your browser version may not work well with NCBI's Web applications. More information here...
1: J Clin Microbiol. 2007 May;45(5):1611-3. Epub 2007 Mar 7.Click here to read Click here to read Links

Evaluation of the AdvanDx VRE EVIGENE assay for detection of vanA in vancomycin-resistant Staphylococcus aureus.

Fosheim GE, Carey RB, Limbago BM.

Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, MS C16, 1600 Clifton Rd., Atlanta, GA 30333, USA.

AdvanDx VRE EVIGENE, a commercial vanA/vanB DNA hybridization assay to identify vancomycin-resistant enterococci (VRE), was evaluated for the detection of vanA in Staphylococcus aureus. Performance was assessed using S. aureus, VRE, and vancomycin-intermediate and -susceptible isolates. The assay demonstrated 100% sensitivity and specificity when analyzed visually and by optical density.

PMID: 17344366 [PubMed - indexed for MEDLINE]

PMCID: PMC1865879

Patient Drug Information

  • Vancomycin (Vancocin® )

    Vancomycin is used to treat colitis (inflammation of the intestine caused by certain bacteria) that may occur after antibiotic treatment. Vancomycin is in a class of medications called glycopeptide antibiotics. It works ...

  • Source: AHFS Consumer Medication Information